The board of directors of the Peijia Medical Limited announced that by January 29, 2021, the company has completed the patient enrollment process for the clinical trial of Shenyi ® Stent Retriever, a major product candidate in the company's neurointerventional pipeline. Shenyi® Stent Retriever is designed to treat patients with acute ischemic stroke by removing fresh thrombus in intracranial vessels in a mechanical thrombectomy procedure. The Company plans to make the registration submission with National Medical Products Administration (NMPA) as soon as it is ready.